- Home
- UNCY vs LSBK Comparison
UNCY vs LSBK Comparison
Compare UNCY & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNCY | LSBK |
|---|---|---|
| Founded | 2016 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.3M | 123.3M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | UNCY | LSBK |
|---|---|---|
| Price | $5.07 | $17.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.67 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 8.1K |
| Earning Date | 05-13-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | N/A | ★ 49.23 |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $582.86 | N/A |
| P/E Ratio | ★ N/A | $65.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.72 | $11.50 |
| 52 Week High | $8.74 | $17.96 |
Technical Indicators
Market Signals| Indicator | UNCY | LSBK |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 55.31 |
| Support Level | $4.18 | $16.64 |
| Resistance Level | $5.20 | $17.76 |
| Average True Range (ATR) | 0.62 | 0.40 |
| MACD | -0.13 | -0.04 |
| Stochastic Oscillator | 25.05 | 30.30 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.